Xilio Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Xilio Therapeutics using advanced sorting and filters.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
XLO | Xilio Therapeutics | -$0.24 | — | — | — | $2.36M | — | — | — | 08/07/2025 | Get Alert |
XLO | Xilio Therapeutics | -$0.59 | -$0.30 | -$0.18 | 40.00% | $0.00 | $6.75M | $2.93M | -56.59% | 05/08/2025 | Get Alert |
XLO | Xilio Therapeutics | -$0.64 | -$0.24 | -$0.20 | 16.67% | $0.00 | — | $1.72M | — | 03/11/2025 | Get Alert |
XLO | Xilio Therapeutics | -$0.61 | -$0.25 | -$0.22 | 12.00% | $0.00 | $3.30M | $2.26M | -31.42% | 11/07/2024 | Get Alert |
XLO | Xilio Therapeutics | -$0.70 | -$0.23 | -$0.24 | -4.35% | $0.00 | — | $2.36M | — | 08/08/2024 | Get Alert |
XLO | Xilio Therapeutics | -$0.83 | -$0.11 | -$0.59 | -436.36% | $0.00 | $30.00M | $0.00 | -100.00% | 05/14/2024 | Get Alert |
XLO | Xilio Therapeutics | -$0.82 | -$0.74 | -$0.64 | 13.51% | $0.00 | — | $0.00 | — | 04/01/2024 | Get Alert |
XLO | Xilio Therapeutics | -$0.72 | -$0.81 | -$0.61 | 24.69% | $0.00 | — | $0.00 | — | 11/09/2023 | Get Alert |
XLO | Xilio Therapeutics | -$0.90 | -$0.87 | -$0.70 | 19.54% | $0.00 | — | $0.00 | — | 08/14/2023 | Get Alert |
XLO | Xilio Therapeutics | -$0.78 | -$0.89 | -$0.83 | 6.74% | $0.00 | — | $0.00 | — | 05/09/2023 | Get Alert |
XLO | Xilio Therapeutics | -$0.98 | -$0.78 | -$0.82 | -5.13% | $0.00 | — | $0.00 | — | 03/02/2023 | Get Alert |
XLO | Xilio Therapeutics | -$21.27 | -$0.88 | -$0.72 | 18.18% | $0.00 | — | $0.00 | — | 11/09/2022 | Get Alert |
XLO | Xilio Therapeutics | -$31.48 | — | -$0.90 | — | $0.00 | — | $0.00 | — | 08/09/2022 | Get Alert |
XLO | Xilio Therapeutics | -$23.53 | — | -$0.78 | — | $0.00 | — | $0.00 | — | 05/12/2022 | Get Alert |
XLO | Xilio Therapeutics | -$31.51 | -$1.17 | -$0.98 | 16.24% | $0.00 | — | $0.00 | — | 03/01/2022 | Get Alert |
XLO | Xilio Therapeutics | -$24.19 | -$1.60 | -$21.27 | -1229.37% | $0.00 | — | $0.00 | — | 12/02/2021 | Get Alert |
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q1 | 2025-05-08 | $-0.18 | $-0.30 | 40.0 % |
Q4 | 2025-03-11 | $-0.20 | $-0.24 | 16.7 % |
Q3 | 2024-11-07 | $-0.22 | $-0.25 | 12.0 % |
Q2 | 2024-08-08 | $-0.24 | $-0.23 | -4.35 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q1 | 2025-05-08 | $2.93M | $6.75M | -56.6 % |
Q3 | 2024-11-07 | $2.26M | $3.30M | -31.4 % |
Q1 | 2024-05-14 | $0 | $30.00M | -100.0 % |
Xilio Therapeutics (XLO) is scheduled to report earnings on August 7, 2025. The last reported earnings were for reported on May 8, 2025 for Q1.
The Actual EPS was $-0.18, which beat the estimate of $-0.30.
The Actual Revenue was $2.9M, which missed the estimate of $6.8M.
Browse earnings estimates, EPS, and revenue on all stocks.